Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria
- 5 February 2019
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 74 (7) , 1081-1087
Abstract
Aims: Comedonecrosis in prostate cancer has always been Gleason pattern 5. However, we aimed to evaluate how intraductal carcinoma (not graded) with comedonecrosis should be considered.Methods and results: From 52 radical prostatectomy patients, 40 were informative and evaluated with immunohistochemistry for basal cells. Clinical outcome was assessed for biochemical recurrence, metastatic disease and the need for adjuvant therapy. Comedonecrosis was predominantly located in intraductal carcinoma (24, 60%). However, nine (23%) had comedonecrosis within invasive cancer and seven (18%) within both invasive and intraductal carcinoma. Extraprostatic extension rarely showed comedonecrosis (5, 13%), but rather perineural invasion within cribriform glands. Tumours were largely high‐stage (15, 38% pT3a and 19, 48% pT3b), with 15 (37%) having positive lymph nodes and four distant metastases. Most cases (25, 63%) had other patterns of Gleason pattern 5 (single cells, solid), although 10 were reclassified as containing no invasive pattern 5. Of these, most were pT3 (eight of 10), but none had positive lymph nodes. Lymph node metastases were more common in patients with invasive cancer containing comedonecrosis (P = 0.02), and the need for androgen deprivation was near significance (P = 0.07), but biochemical recurrence was not significantly different (P = 0.58).Conclusions: Prostate cancer with comedonecrosis is often intraductal; however, these tumours are largely high‐stage, showing a higher rate of positive lymph nodes with invasive comedonecrosis. Immunohistochemistry may be considered when comedonecrosis may significantly change the tumour grade. However, it is not clear at present that excluding intraductal carcinoma from the grade is superior to including it in grading when it is associated with high‐grade invasive cancer.Keywords
This publication has 23 references indexed in Scilit:
- Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal CarcinomaAmerican Journal of Surgical Pathology, 2015
- Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologistsAnnals of Diagnostic Pathology, 2014
- Intraductal carcinoma of the prostate: the whole storyPathology, 2013
- Prognostic G leason grade grouping: data based on the modified G leason scoring systemBJU International, 2013
- Intraductal Carcinoma of the ProstateArchives of Pathology & Laboratory Medicine, 2012
- Intraductal Carcinoma of the Prostate Without Invasive Carcinoma on Needle Biopsy: Emphasis on Radical Prostatectomy FindingsJournal of Urology, 2010
- Original Gleason System Versus 2005 ISUP Modified Gleason System: The Importance of Indicating Which System Is Used in the Patient’s Pathology and Clinical ReportsEuropean Urology, 2010
- Benign Mimickers of Prostate Adenocarcinoma on Needle Biopsy and Transurethral ResectionSurgical Pathology Clinics, 2008
- My approach to intraductal lesions of the prostate glandJournal of Clinical Pathology, 2007
- Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significanceLaboratory Investigation, 2006